ArticleJournal of Cancer2018

Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer.

Shigeyoshi Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.